Emerging issues in cystic fibrosis newborn screening
Authors:
- Carlo CastellaniCCCarlo Castellani
- John MassieJMJohn Massie
- 1 November 2010
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Pulmonary Medicine
- Vol. 16 (6) , 584-590
Abstract
There has been a rise in the introduction of cystic fibrosis (CF) newborn screening (NBS) programs in recent years. Despite many long running and successful programs with established protocols, new strategies are being developed in an effort to improve sensitivity and specificity. In light of the emerging issues of NBS, new algorithms have been implemented and are reviewed here. The increase in mixing of populations affects both immunoreactive trypsinogen values and sensitivity of genetic analysis in NBS. Adjustments to the mutation panel are not always possible. Algorithms adding nongenetic tiers may prove to be an alternative. The interpretation of the sweat test in neonates has been changing too, and there is now agreement that the upper limit of a normal sweat chloride is 29 mmol/l. Infants identified by NBS with a sweat chloride of 30-59 mmol/l and no evidence of two CF-causing mutations require further evaluation and often a long clinical follow-up before CF may be confirmed or excluded. Some NBS programs have reported a steady reduction in the incidence of CF, traceable to prenatal diagnosis on subsequent pregnancies and population-based carrier screening. Although there is not one universal CF NBS protocol that will suit the heterogeneous needs of diverse regions, many options for adjusting algorithms to local conditions are now available.Keywords
This publication has 51 references indexed in Scilit:
- Cystic Fibrosis Foundation Practice Guidelines for the Management of Infants with Cystic Fibrosis Transmembrane Conductance Regulator-Related Metabolic Syndrome during the First Two Years of Life and BeyondThe Journal of Pediatrics, 2009
- A New Cystic Fibrosis Newborn Screening Algorithm: IRT/IRT1↑/DNAThe Journal of Pediatrics, 2009
- Diagnosis of Cystic Fibrosis by Sweat Testing: Age-Specific Reference IntervalsThe Journal of Pediatrics, 2008
- Guidelines for Diagnosis of Cystic Fibrosis in Newborns through Older Adults: Cystic Fibrosis Foundation Consensus ReportThe Journal of Pediatrics, 2008
- Implementation of the French Nationwide Cystic Fibrosis Newborn Screening ProgramThe Journal of Pediatrics, 2008
- Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practiceJournal of Cystic Fibrosis, 2008
- Potential impact of newborn screening for cystic fibrosis on child survival: A systematic review and analysisThe Journal of Pediatrics, 2006
- The Influence of Newborn Screening for Cystic Fibrosis on Pulmonary Outcomes in New South WalesThe Journal of Pediatrics, 2005
- Review of outcomes of neonatal screening for cystic fibrosis versus non-screening in EuropeThe Journal of Pediatrics, 2005
- Combining Immunoreactive Trypsinogen and Pancreatitis-Associated Protein Assays, a Method of Newborn Screening for Cystic Fibrosis that Avoids DNA AnalysisThe Journal of Pediatrics, 2005